Just a moment, the page is loading...

VIIV-207187




A Double-Blind (Sponsor Unblinded), Randomized, Placebo-Controlled, Single and Repeated Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK3640254 in Healthy Participants
GSK3640254
207187
NCT03231943 2017-001367-21
Infection, Human Immunodeficiency Virus
Phase 1
This study is available in CDISC format.
April 2021